[go: up one dir, main page]

DK79985A - Kloning af dna for protozoelle antigener og dets anvendelse - Google Patents

Kloning af dna for protozoelle antigener og dets anvendelse Download PDF

Info

Publication number
DK79985A
DK79985A DK79985A DK79985A DK79985A DK 79985 A DK79985 A DK 79985A DK 79985 A DK79985 A DK 79985A DK 79985 A DK79985 A DK 79985A DK 79985 A DK79985 A DK 79985A
Authority
DK
Denmark
Prior art keywords
antigenes
protocol
cloning dna
cloning
dna
Prior art date
Application number
DK79985A
Other languages
English (en)
Other versions
DK79985D0 (da
Inventor
Anthony Arthur Holder
Michael James Lockyer
Jasbir Singh Sandhu
Valentina Riveros-Moreno
Karel Gerrit Odink
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB848404692A external-priority patent/GB8404692D0/en
Priority claimed from GB848424340A external-priority patent/GB8424340D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK79985D0 publication Critical patent/DK79985D0/da
Publication of DK79985A publication Critical patent/DK79985A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK79985A 1984-02-22 1985-02-21 Kloning af dna for protozoelle antigener og dets anvendelse DK79985A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB848404692A GB8404692D0 (en) 1984-02-22 1984-02-22 Cloning of dna for protozoal antigens
GB848424340A GB8424340D0 (en) 1984-09-26 1984-09-26 Cloning of dna

Publications (2)

Publication Number Publication Date
DK79985D0 DK79985D0 (da) 1985-02-21
DK79985A true DK79985A (da) 1985-08-23

Family

ID=26287348

Family Applications (1)

Application Number Title Priority Date Filing Date
DK79985A DK79985A (da) 1984-02-22 1985-02-21 Kloning af dna for protozoelle antigener og dets anvendelse

Country Status (14)

Country Link
US (1) US5597708A (da)
EP (1) EP0154454B1 (da)
JP (2) JP2584733B2 (da)
AT (1) ATE64957T1 (da)
AU (1) AU592749B2 (da)
CA (1) CA1340103C (da)
DE (1) DE3583347D1 (da)
DK (1) DK79985A (da)
GB (1) GB2154592A (da)
HU (1) HU200794B (da)
IL (1) IL74409A (da)
NZ (1) NZ211191A (da)
PH (1) PH25993A (da)
ZW (1) ZW2485A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3584300D1 (de) * 1984-02-21 1991-11-14 Nat Res Dev Herstellung von malaria-impfstoffen.
IL76338A (en) * 1984-09-11 1994-08-26 Saramane Pty Ltd Plasmodium plasmodium immunogenic polypeptides, AND molecules encoding them, a method for preparing the polypeptides and preparations containing the polypeptide
EP0217877A4 (en) * 1985-04-11 1988-03-30 Inst Medical W & E Hall VERY REPEATABLE ANTIGENS FROM PLASMODIUM FALCIPARUM.
US4978621A (en) * 1985-09-03 1990-12-18 Scripps Clinic And Research Foundation Merozoite surface antigens
EP0252098A4 (en) * 1985-12-24 1989-11-29 Inst Medical W & E Hall ANTIGENS IN THE ASEXUAL BLOOD PHASE OF -i (PLASMODIUM FALCIPARUM).
EP0252588A3 (en) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine
US5001225A (en) * 1986-12-08 1991-03-19 Georgetown University Monoclonal antibodies to a pan-malarial antigen
GB8706599D0 (en) * 1987-03-19 1987-04-23 Hoffmann La Roche Plasmodium falciparum merozoite antigen peptides
DE3737238A1 (de) * 1987-11-03 1989-05-18 Behringwerke Ag Rekombinantes histidinreiches protein (37 kd antigen) von plasmodium falciparum, seine herstellung und verwendung
AT388934B (de) * 1987-11-13 1989-09-25 Wellcome Found Rekombinationskonjugatprotein und neue vakzinen
DE3831351A1 (de) * 1987-12-30 1989-07-13 Behringwerke Ag Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung
US6333406B1 (en) 1988-08-12 2001-12-25 Joseph W. Inselburg Gene encoding protein antigens of Plasmodium falciparum and uses therefor
US5756101A (en) * 1991-07-01 1998-05-26 Pasteur Merieux Serums Et Vaccins Malaria recombinant poxvirus
US6855316B1 (en) * 1994-02-14 2005-02-15 University Of Hawaii Baculovirus produced Plasmodium falciparum vaccine
FR2744724B1 (fr) * 1996-02-14 2002-08-02 Pasteur Institut Proteine recombinante contenant un fragment c-terminal de la proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
FR2744723A1 (fr) * 1996-02-14 1997-08-14 Pasteur Institut Proteine recombinante contenant un fragment c-terminal d'une proteine msp-1 d'un plasmodium infectieux pour l'homme pour la production de vaccins anti-paludiques
DE19640817A1 (de) 1996-10-02 1998-05-14 Hermann Prof Dr Bujard Rekombinantes Herstellungsverfahren für ein vollständiges Malaria-Antigen gp190/MSP 1
UY27304A1 (es) 2001-05-24 2002-12-31 Avanir Pharmaceuticals Inhibidores del factor inhibidor de la migración de los macrófagos y métodos para su identificación
US20040082048A1 (en) * 2002-10-15 2004-04-29 Viswanath Nittala Venkata Narasimha Genes and protein sequences useful as drug targets for therapeutic action against protozoa
TW200418829A (en) * 2003-02-14 2004-10-01 Avanir Pharmaceutics Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
EP1656376A1 (en) 2003-08-22 2006-05-17 Avanir Pharmaceuticals Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases
US20060229314A1 (en) 2005-03-24 2006-10-12 Jagadish Sircar Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors
GB0605689D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic compounds
US7931908B2 (en) 2007-02-23 2011-04-26 Philadelphia Health Education Corporation Chimeric MSP-based malaria vaccine

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
GB2145092B (en) * 1983-01-28 1988-04-07 Univ New York Protective peptide antigen
IL65496A (en) * 1981-04-15 1985-10-31 Wellcome Found Protozoal antigen,its preparation and vaccine containing it
AU569722B2 (en) * 1983-01-28 1988-02-18 Saramane Pty Ltd Expression of plasmodium falciparum polypeptides from cloned cdna
US4767622A (en) * 1983-08-19 1988-08-30 University Of Illinois Method and materials for development of immunological responses protective against malarial infection
GB8404378D0 (en) * 1984-02-20 1984-03-28 Biogen Nv Dna sequence recombinant dna molecules

Also Published As

Publication number Publication date
HUT37460A (en) 1985-12-28
GB8504429D0 (en) 1985-03-27
CA1340103C (en) 1998-10-27
EP0154454B1 (en) 1991-07-03
HU200794B (en) 1990-08-28
NZ211191A (en) 1988-01-08
JP2893626B2 (ja) 1999-05-24
JPH06189772A (ja) 1994-07-12
JP2584733B2 (ja) 1997-02-26
ATE64957T1 (de) 1991-07-15
GB2154592A (en) 1985-09-11
JPS6119490A (ja) 1986-01-28
AU592749B2 (en) 1990-01-25
IL74409A0 (en) 1985-05-31
EP0154454A1 (en) 1985-09-11
IL74409A (en) 1994-08-26
DE3583347D1 (de) 1991-08-08
PH25993A (en) 1992-01-13
US5597708A (en) 1997-01-28
AU3904685A (en) 1985-09-05
ZW2485A1 (en) 1986-09-24
DK79985D0 (da) 1985-02-21

Similar Documents

Publication Publication Date Title
DK79985A (da) Kloning af dna for protozoelle antigener og dets anvendelse
DE68910713D1 (de) Isolierung, Reinigung, Charakterisierung, Klonierung und Sequenzierung von N-alpha-Acetyltransferase.
ATE114169T1 (de) Morphogenetisches knochenprotein.
IT1222394B (it) Processo per la preparazione di 2,2,6,6 tetrametil 4 piperidilammine
FI906212A7 (fi) HIV-proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDSin hoidossa
DK122687A (da) Polypeptid, dna og anvendelse deraf
FR2563434B1 (fr) Vaccin contre la rage et procede pour sa preparation
DE3582203D1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparum-antigenen.
FI885237A7 (fi) Menetelmä yhdistelmä-E. colissa ilmennetyn P. falciparum-CS-proteiinir okotteen eristämiseksi ja puhdistamiseksi
DE3789530D1 (de) Klonierung und Expression des sauren Fibroblastenwachstumsfaktors.
DE10399004I2 (de) Klonierung und expression von Wirtssch}tzenden immunogenen des Infektioesen Bursavirus (ibdv).
FI883005A7 (fi) Promoottoreita vieras-DNA:n ilmaisemiseksi metylotrofisissa bakteereissa, niiden talteenotto ja niiden käyttö.
DE3768459D1 (de) Duese zur zufuhr von behandlungsdraht.
DE69536025D1 (de) Methode zur direkten Klonierung von Nukleasegenen in E.coli
DK575787A (da) Rekombinant hcmv-afledt plasmid, dets fremstilling og anvendelse
DE3881123D1 (de) Klonieren von fuer einen antibakteriellen polypeptidvorlaeufer kodierender dna und expression des vorlaeufers.
DE3781865D1 (de) Klonierung von dns, welche einen menschlichen gip-vorlaeufer kodiert und expressionsverfahren des vorlaeufers.
ZA902436B (en) Purification of c.pseudotuberculosis toxin,and cloning and expression of toxin gene
PT88098A (pt) Processo de clonacao e expressao de genes codificando para proteinas constituintes de edificios funcionais organizados
ATE61818T1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparumantigenen.
NO910331D0 (no) Rekombinant plasmid, fremgangsmaate til dets fremstilling og anvendelse av plasmidet i produksjonen av proteiner.
IL85239A0 (en) Recombinant alveolar surfactant protein,its production and purification and pharmaceutical compositions containing it
DK587688A (da) Polypeptid, dets anvendelse og fremstilling
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
ATE84315T1 (de) Rekombinante dna zur reprimierbaren und induzierbaren expression von fremdgenen.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment